GLP2-TZ is a synthetic dual GIP/GLP-1 receptor agonist (Tirzepatide analog) studied for incretin and metabolic pathway research. ≥99% HPLC-verified lyophilized powder. For research use only.
Engages both GIP and GLP-1 receptors in a single molecule
Every lot independently verified by third-party laboratories
Full Certificate of Analysis with HPLC, mass spec, and endotoxin data
GLP2-TZ is a synthetic 39-amino acid peptide that functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It features a C20 fatty diacid moiety enabling extended pharmacokinetic properties.
This compound represents a novel mechanism of action through simultaneous engagement of two incretin receptors, and has been the subject of extensive Phase III clinical research published in leading medical journals.
Manufactured under strict cGMP-equivalent protocols and verified to ≥99% purity via reverse-phase HPLC. A full Certificate of Analysis is included with every order.
Supplied as a lyophilized white powder. Soluble in sterile water and bacteriostatic water. For research and laboratory use only.
GLP2-TZ is a synthetic 39-amino acid dual GIP and GLP-1 receptor agonist peptide. It is intended exclusively for in-vitro and laboratory research applications.
Verified at ≥99% purity via reverse-phase HPLC. Each lot includes mass spectrometry confirmation and endotoxin testing. Full COA included with every order.
Lyophilized: -20°C long-term, stable at 2–8°C for 90 days. Reconstituted: 2–8°C, use within 28 days. Protect from light.
Yes. Every order includes a lot-specific COA with HPLC chromatography, mass spec data, peptide content, and endotoxin levels.
Orders before 2PM EST ship same day. Standard delivery is 2–4 business days within the continental US. All orders include tracking.
Still have questions about GLP2-TZ or any of our research compounds?
Contact Our Research Team →
